Economic Implications of Preventing Major Cardiovascular and Limb Events with Rivaroxaban plus Aspirin in Patients with Coronary or Peripheral Artery Disease in the United States

بواسطة Hernandez, Luis, Shah, Anshul, Zhao, Qi, Milentijevic, Dejan, Kharat, Akshay
الحاوية / القاعدة Am Health Drug Benefits (2020)

Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension

بواسطة Burudpakdee, Chakkarin, Shah, Anshul, Joish, Vijay N., Divers, Christine H., Yaldo, Avin
الحاوية / القاعدة Am Health Drug Benefits (2014)

Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusion

بواسطة Bradshaw, Steven E., Gala, Smeet, Nanavaty, Merena, Shah, Anshul, Mwamburi, Mkaya, Kefalas, Panos
الحاوية / القاعدة BMC Ophthalmol (2016)

Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan

بواسطة Hernandez, Luis, Kuwabara, Hiroyo, Shah, Anshul, Yamabe, Kaoru, Burnett, Heather, Fahrbach, Kyle, Koufopoulou, Maria, Iwakiri, Ryuichi
الحاوية / القاعدة Pharmacoeconomics (2019)